Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
Authors
Keywords
-
Journal
MEDIATORS OF INFLAMMATION
Volume 2018, Issue -, Pages 1-11
Publisher
Hindawi Limited
Online
2018-02-19
DOI
10.1155/2018/3424136
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IFN-α Negatively Regulates the Expression of Endothelial Nitric Oxide Synthase and Nitric Oxide Production: Implications for Systemic Lupus Erythematosus
- (2017) Joy Jones Buie et al. JOURNAL OF IMMUNOLOGY
- Longterm Hydroxychloroquine Therapy and Low-dose Aspirin May Have an Additive Effectiveness in the Primary Prevention of Cardiovascular Events in Patients with Systemic Lupus Erythematosus
- (2017) Serena Fasano et al. JOURNAL OF RHEUMATOLOGY
- Endothelial Alterations in Systemic Lupus Erythematosus and Rheumatoid Arthritis: Potential Effect of Monocyte Interaction
- (2017) Laura Atehortúa et al. MEDIATORS OF INFLAMMATION
- Overexpression of the Cytokine BAFF and Autoimmunity Risk
- (2017) Maristella Steri et al. NEW ENGLAND JOURNAL OF MEDICINE
- Endothelial dysfunction in systemic lupus erythematosus – a case-control study and an updated meta-analysis and meta-regression
- (2017) Anselm Mak et al. Scientific Reports
- Excess atherosclerosis in systemic lupus erythematosus,—A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls
- (2017) Johanna T. Gustafsson et al. PLoS One
- Predictors of flares in Systemic Lupus Erythematosus: Preventive therapeutic intervention based on serial anti-dsDNA antibodies assessment. Analysis of a monocentric cohort and literature review
- (2016) Alberto Floris et al. AUTOIMMUNITY REVIEWS
- Longitudinal Evaluation of Lipoprotein Variables in Systemic Lupus Erythematosus Reveals Adverse Changes with Disease Activity and Prednisone and More Favorable Profiles with Hydroxychloroquine Therapy
- (2016) L. Durcan et al. JOURNAL OF RHEUMATOLOGY
- Dyslipidemia in systemic lupus erythematosus: just another comorbidity?
- (2016) Konstantinos Tselios et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Brief Report: Trends in Hospitalizations Due to Acute Coronary Syndromes and Stroke in Patients With Systemic Lupus Erythematosus, 1996 to 2012
- (2016) Maria G. Tektonidou et al. Arthritis & Rheumatology
- Twenty-year brain magnetic resonance imaging follow-up study in Systemic Lupus Erythematosus: Factors associated with accrual of damage and central nervous system involvement
- (2015) Matteo Piga et al. AUTOIMMUNITY REVIEWS
- Hydroxychloroquine Blood Levels in Systemic Lupus Erythematosus: Clarifying Dosing Controversies and Improving Adherence
- (2015) L. Durcan et al. JOURNAL OF RHEUMATOLOGY
- Population-based analysis of hospitalizations in a West-European region revealed major changes in hospital utilization for patients with systemic lupus erythematosus over the period 2001–2012
- (2015) M Piga et al. LUPUS
- Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study
- (2015) Yi-Ming Chen et al. RHEUMATOLOGY
- Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus
- (2015) Agostino Virdis et al. ARTHRITIS RESEARCH & THERAPY
- Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases
- (2015) K. D. Rainsford et al. INFLAMMOPHARMACOLOGY
- Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
- (2014) Ronald F van Vollenhoven et al. ANNALS OF THE RHEUMATIC DISEASES
- Chronic Hydroxychloroquine Improves Endothelial Dysfunction and Protects Kidney in a Mouse Model of Systemic Lupus Erythematosus
- (2014) Manuel Gómez-Guzmán et al. HYPERTENSION
- Systemic lupus erythematosus
- (2014) Larissa Lisnevskaia et al. LANCET
- Mortality Associated With Systemic Lupus Erythematosus in France Assessed by Multiple-Cause-of-Death Analysis
- (2014) Guillemette Thomas et al. Arthritis & Rheumatology
- TLR2 and TLR4 in Autoimmune Diseases: a Comprehensive Review
- (2013) Yu Liu et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients
- (2013) JC Silva et al. Clinics
- Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment
- (2013) Cristen B. Chafin et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The Early Protective Effect of Hydroxychloroquine on the Risk of Cumulative Damage in Patients with Systemic Lupus Erythematosus
- (2013) P. S. Akhavan et al. JOURNAL OF RHEUMATOLOGY
- Antiphospholipid syndrome nephropathy (APSN) in patients with lupus nephritis: a retrospective clinical and renal pathology study
- (2013) Gian Luca Erre et al. RHEUMATOLOGY INTERNATIONAL
- Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
- (2012) Nathalie Costedoat-Chalumeau et al. ANNALS OF THE RHEUMATIC DISEASES
- Predictors of organ damage in systemic lupus erythematosus: The Hopkins Lupus Cohort
- (2012) Michelle Petri et al. ARTHRITIS AND RHEUMATISM
- Semiquantified Noncalcified Coronary Plaque in Systemic Lupus Erythematosus
- (2012) A. N. KIANI et al. JOURNAL OF RHEUMATOLOGY
- Hydroxychloroquine reduces low-density lipoprotein cholesterol levels in systemic lupus erythematosus: a longitudinal evaluation of the lipid-lowering effect
- (2012) E Cairoli et al. LUPUS
- Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort
- (2012) R Willis et al. LUPUS
- New insights into mechanisms of therapeutic effects of antimalarial agents in SLE
- (2012) Daniel J. Wallace et al. Nature Reviews Rheumatology
- Accelerated atherosclerosis in patients with SLE—mechanisms and management
- (2012) Brian J. Skaggs et al. Nature Reviews Rheumatology
- Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus
- (2012) Karim Sacre et al. ARTHRITIS RESEARCH & THERAPY
- Netting Neutrophils Induce Endothelial Damage, Infiltrate Tissues, and Expose Immunostimulatory Molecules in Systemic Lupus Erythematosus
- (2011) E. Villanueva et al. JOURNAL OF IMMUNOLOGY
- Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
- (2011) A. Kuznik et al. JOURNAL OF IMMUNOLOGY
- Implications of immunosuppressive agents in cardiovascular risks and carotid intima media thickness among lupus nephritis patients
- (2011) S Sazliyana et al. LUPUS
- Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE
- (2011) Deborah P. M. Symmons et al. Nature Reviews Rheumatology
- The interplay of inflammation and cardiovascular disease in systemic lupus erythematosus
- (2011) J Michelle Kahlenberg et al. ARTHRITIS RESEARCH & THERAPY
- Markers of oxidative and nitrosative stress in systemic lupus erythematosus: Correlation with disease activity
- (2010) Gangduo Wang et al. ARTHRITIS AND RHEUMATISM
- Antimalarial treatment may have a time-dependent effect on lupus survival: Data from a multinational Latin American inception cohort
- (2010) Samuel K. Shinjo et al. ARTHRITIS AND RHEUMATISM
- The protective effect of antimalarial drugs on thrombovascular events in systemic lupus erythematosus
- (2010) Hyejung Jung et al. ARTHRITIS AND RHEUMATISM
- Network analysis of associations between serum interferon-α activity, autoantibodies, and clinical features in systemic lupus erythematosus
- (2010) Corinna E. Weckerle et al. ARTHRITIS AND RHEUMATISM
- From endothelial dysfunction to atherosclerosis
- (2010) S. Sitia et al. AUTOIMMUNITY REVIEWS
- Oxidative stress in systemic lupus erythematosus: Relationship to Th1 cytokine and disease activity
- (2010) Dilip Shah et al. IMMUNOLOGY LETTERS
- Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis
- (2010) Q. Huang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- The Relation of Interleukin 17 (IL-17) and IL-23 to Th1/Th2 Cytokines and Disease Activity in Systemic Lupus Erythematosus
- (2010) M. Y. MOK et al. JOURNAL OF RHEUMATOLOGY
- Hydroxychloroquine and Glycemia in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus
- (2010) S. K. PENN et al. JOURNAL OF RHEUMATOLOGY
- Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis
- (2010) Young Hee Rho et al. ARTHRITIS CARE & RESEARCH
- European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies
- (2009) M. Mosca et al. ANNALS OF THE RHEUMATIC DISEASES
- Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drug
- (2009) J. H. Rand et al. BLOOD
- Metabolic Syndrome Is Associated with Increased Arterial Stiffness and Biomarkers of Subclinical Atherosclerosis in Patients with Systemic Lupus Erythematosus
- (2009) J. M. SABIO et al. JOURNAL OF RHEUMATOLOGY
- Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis
- (2009) CP Chung et al. LUPUS
- Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review
- (2008) G Ruiz-Irastorza et al. ANNALS OF THE RHEUMATIC DISEASES
- Inflammation‐associated insulin resistance: Differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms
- (2008) Cecilia P. Chung et al. ARTHRITIS AND RHEUMATISM
- Interferon gamma: A master regulator of atherosclerosis
- (2008) James E. McLaren et al. CYTOKINE & GROWTH FACTOR REVIEWS
- Diabetes mellitus complicating systemic lupus erythematosus – analysis of the UCL lupus cohort and review of the literature
- (2008) S Cortes et al. LUPUS
- Hydroxychloroquine: the cornerstone of lupus therapy
- (2008) G Ruiz-Irastorza et al. LUPUS
- Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus
- (2008) E. Svenungsson et al. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started